In accordance with the Food and Drug Safety Administration's administrative order (Drug Management Division-No. 7389, effective date 2011.12.29) based on the results of the 2010 pharmaceutical literature re-evaluation, the efficacy, dosage, and precautions for use of Gabapen Capsule, Roxonal Tablet, Melix Capsule, Acer Tablet, Acer Capsule, Eldoral Tablet, Oxfilin Tablet, Ketoran Injection, and Topim Tablet were reviewed. It has changed.
For further details, please refer to the ‘Product Introduction’ section and attached documents.